Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

VKTX | Viking Therapeutics Inc

Index	RUT	P/E	-	EPS (ttm)	-0.91	Insider Own	10.16%	Shs Outstand	100.03M	Perf Week	-15.56%
Market Cap	1.17B	Forward P/E	-	EPS next Y	-1.01	Insider Trans	-10.31%	Shs Float	89.87M	Perf Month	-14.16%
Income	-74.09M	PEG	-	EPS next Q	-0.22	Inst Own	71.72%	Short Float / Ratio	14.37% / 5.73	Perf Quarter	-35.69%
Sales	0.00M	P/S	-	EPS this Y	0.14%	Inst Trans	-0.31%	Short Interest	12.91M	Perf Half Y	31.81%
Book/sh	3.86	P/B	3.02	EPS next Y	-12.70%	ROA	-25.45%	Target Price	19.50	Perf Year	309.30%
Cash/sh	3.93	P/C	2.97	EPS next 5Y	-	ROE	-26.88%	52W Range	2.53 - 25.72	Perf YTD	24.10%
Dividend	-	P/FCF	-	EPS past 5Y	-2.56%	ROI	-19.13%	52W High	-54.65%	Beta	0.54
Dividend %	-	Quick Ratio	29.63	Sales past 5Y	0.00%	Gross Margin	-	52W Low	360.25%	ATR	0.79
Employees	21	Current Ratio	29.63	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	26.90	Volatility	5.89% 5.31%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	14.41%	Profit Margin	-	Rel Volume	1.51	Prev Close	12.88
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Jul 26 AMC	Payout	-	Avg Volume	2.25M	Price	11.66
Recom	1.09	SMA20	-18.41%	SMA50	-18.84%	SMA200	-19.32%	Volume	3,399,151	Change	-9.43%

Date	Action	Analyst	Rating Change	Price Target Change
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14
May-05-20	Initiated	Chardan Capital Markets	Buy	$15
May-01-20	Initiated	BTIG Research	Buy	$9
Jul-16-19	Initiated	Oppenheimer	Outperform	$12
Jun-25-19	Initiated	Stifel	Buy
Mar-29-19	Upgrade	SVB Leerink	Mkt Perform → Outperform	$10 → $21
Mar-14-19	Reiterated	Maxim Group	Buy	$28 → $20
Feb-22-19	Initiated	SVB Leerink	Mkt Perform
Dec-12-18	Initiated	B. Riley FBR	Buy	$16
Nov-19-18	Upgrade	Raymond James	Outperform → Strong Buy
Sep-18-18	Reiterated	Raymond James	Outperform	$15 → $43
Sep-18-18	Reiterated	Maxim Group	Buy	$14 → $28
Sep-18-18	Reiterated	H.C. Wainwright	Buy	$15 → $28
Jul-20-18	Initiated	SunTrust	Buy	$14
Jun-28-18	Initiated	Raymond James	Outperform

Show Previous Ratings

Sep-07-23 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Sep-06-23 07:03AM	Viking Therapeutics Announces Initiation of Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity (PR Newswire)
Aug-28-23 10:22AM	15 Most Shorted Stocks That Are Loved By Analysts (Insider Monkey)
Aug-17-23 09:31AM	15 Best-Performing Stocks in the Last 12 Months (Insider Monkey)
Aug-16-23 07:07PM	The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023 (InvestorPlace)
11:45AM	Loading…
Aug-09-23 11:45AM	Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings (Zacks)
Aug-08-23 11:45AM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today (Motley Fool) +11.88%
Aug-02-23 11:15AM	2 Magnificient Growth Stocks I'm Buying in August (Motley Fool)
Jul-29-23 11:39AM	10 Oversold Biotech Stocks to Buy (Insider Monkey)
Jul-27-23 09:51AM	Q2 2023 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-26-23 04:05PM	Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
Jul-22-23 06:14AM	3 Small-Cap Stocks That Could Be Big-Time Winners (Motley Fool)
Jul-19-23 04:05PM	Viking Therapeutics to Report Financial Results for Second Quarter 2023 on July 26, 2023 (PR Newswire)
Jul-12-23 10:05AM	2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher (Motley Fool)
Jul-10-23 09:32AM	Viking Therapeutics (VKTX) Surges 64% Year to Date: Here's Why (Zacks)
09:29AM	Loading…
09:29AM	Sotherly Hotels' (SOHO) Q2 Operating Trend Reflects Solid Demand (Zacks)
Jul-07-23 06:32PM	The 3 Best Momentum Stocks to Buy in July (InvestorPlace)
08:00AM	Obesity Drugs Wont Starve These Other Potential Blockbusters (The Wall Street Journal)
Jul-05-23 08:14PM	Oppenheimer Predicts up to 140% Rally for These 3 Stocks Heres Why They Have Solid Upside (TipRanks)
Jun-29-23 02:00PM	The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 (InvestorPlace)
08:30AM	Better Buy: Nano-X Imaging vs. Viking Therapeutics (Motley Fool)
Jun-27-23 01:53PM	Why Viking Therapeutics Is Plunging Today (Motley Fool) -18.22%
Jun-26-23 11:39PM	Why Viking Therapeutics Stock Is Crashing Today (Motley Fool) -11.08%
Jun-22-23 06:40AM	3 Biotech Stocks to Buy as Companies Ink Major Deals (InvestorPlace)
Jun-20-23 10:15AM	After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy? (Motley Fool)
05:50AM	Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money. (Motley Fool)
05:25AM	If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position (Motley Fool)
Jun-17-23 09:06AM	Could Viking Therapeutics Stock Help You Become a Millionaire? (Motley Fool)
Jun-13-23 11:15AM	Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics? (Motley Fool)
Jun-12-23 10:15AM	Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years (Motley Fool)
11:14AM	Loading…
Jun-08-23 11:14AM	Top Healthcare Stocks for June 2023 (Investopedia)
10:07AM	This Red-Hot Growth Stock Has Soared 885% in Just 12 Months (Motley Fool)
Jun-07-23 07:13AM	10 Stocks Wall Street Analysts and Billionaires Are Crazy About (Insider Monkey)
May-31-23 02:49PM	Why Viking Therapeutics Stock Is Heating Up Today (Motley Fool) +6.40%
May-30-23 05:38AM	2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street (Motley Fool)
May-26-23 06:19AM	3 Biotech Stocks Sitting on Huge-Upside Catalysts (InvestorPlace)
May-24-23 11:59AM	Here's Why Hepion Pharma (HEPA) is Up More Than 80% in Two Days (Zacks)
May-22-23 12:02PM	Intercept (ICPT) NASH Treatment Fails to Get GIDAC Recommendation (Zacks) +6.01%
06:40AM	Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich or Broke. (InvestorPlace)
May-21-23 03:28PM	7 Stocks That Wall Street Analysts Are Loving in May (InvestorPlace)
May-19-23 03:27PM	Boeing, First Solar, and Viking Therapeutics Notch Stellar Performances Over the Last Year (Barrons.com)
May-18-23 02:52PM	Why Viking Therapeutics Stock Is Buckling Today (Motley Fool) -5.04%
12:12PM	Intercept (ICPT) Down Ahead of GIDAC Meeting for NASH Treatment (Zacks)
May-17-23 01:59PM	Viking (VKTX) Up 12% as VKTX-2809 Meets Goals in NASH Study (Zacks)
May-16-23 04:12PM	Top 1% Biotech Viking Yo-Yos, But Hits A Record, On NASH Enthusiasm (Investor's Business Daily) +12.07%
03:52PM	Why Viking Therapeutics Stock Bolted Higher Today (Motley Fool)
11:29AM	Top 1% Biotech Viking Therapeutics Backs Off Its Record Run On NASH Enthusiasm (Investor's Business Daily)
09:32AM	Why Top 1% Biotech Viking Therapeutics Is At The Brink Of A Record High (Investor's Business Daily)
07:31AM	UPDATE 2-Viking Therapeutics's NASH drug succeeds in mid-stage trial, shares jump (Reuters)
07:00AM	Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) (PR Newswire)
May-11-23 08:39AM	Top Healthcare Stocks for May 2023 (Investopedia)
May-09-23 03:40PM	Why Viking Therapeutics Stock Wobbled Today (Motley Fool)
May-01-23 04:28PM	Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today (Motley Fool)
Apr-27-23 02:56PM	Why Viking Therapeutics Stock Briefly Popped Today (Motley Fool)
06:31AM	Q1 2023 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-26-23 04:05PM	Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
Apr-25-23 08:45AM	3 Top Biotech Stocks Defying the Bear Market (Motley Fool) -6.80%
07:12AM	As Viking Therapeutics, Inc. (NASDAQ:VKTX) gains 8.7%, insiders who bought last year may be wishing they had bet higher (Simply Wall St.)
Apr-20-23 04:05PM	Viking Therapeutics to Report Financial Results for First Quarter 2023 on April 26, 2023 (PR Newswire)
Apr-19-23 02:42PM	Top Biotech Stocks for Q2 2023 (Investopedia)
Apr-11-23 04:05PM	Viking Therapeutics to Present at 22nd Annual Needham Healthcare Conference (PR Newswire)
Apr-07-23 06:40PM	Tillys, American Public Education Stock See Action From Activist Investors (Barrons.com)
Apr-03-23 05:06PM	Viking Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Underwriters' Option to Purchase Additional Shares (PR Newswire) +5.53%
Apr-01-23 01:43PM	5 Best Stocks to Buy in April (Motley Fool)
Mar-30-23 02:06PM	Why Shares of Viking Therapeutics Skyrocketed This Week (Motley Fool) +8.79%
01:48AM	Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock (PR Newswire)
Mar-29-23 04:10PM	Novo Hits Another Record High As WHO Considers A Key Move In Obesity (Investor's Business Daily)
04:01PM	Viking Therapeutics Announces Proposed Public Offering of Common Stock (PR Newswire)
12:51PM	The Government Move That Could Drive Obesity Drugs And Lilly, Novo Shares (Investor's Business Daily)
11:24AM	Biotech Stock Roundup: VKTX, BMEA, ITCI Soar on Study Data, INCY Faces Setback (Zacks)
07:45AM	Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run (Motley Fool)
05:54AM	Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%? (Motley Fool)
Mar-28-23 04:18PM	Viking Rockets 69% After Dropping This Scorcher In The Obesity Treatment Battle (Investor's Business Daily) +69.30%
04:18PM	Viking Rockets 63% After Dropping This Scorcher In The Obesity Treatment Battle (Investor's Business Daily)
12:32PM	Viking Therapeutics Steps Into The Obesity Ring And Catapults 63% (Investor's Business Daily)
07:03AM	Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Oral Formulation of Dual GLP-1/GIP Receptor Agonist VK2735 (PR Newswire)
07:00AM	UPDATE 2-Viking Therapeutics obesity drug shows promise in early-stage study, shares soar (Reuters)
06:33AM	Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 (PR Newswire)
Mar-27-23 05:47AM	Is Viking Therapeutics a Smart Buy on the Dip? (Motley Fool)
Mar-15-23 03:28PM	We're Not Very Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Rate (Simply Wall St.)
Mar-07-23 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Feb-23-23 10:30AM	2 Surging Healthcare Stocks That Are Still Worth Buying (Motley Fool)
Feb-11-23 07:05AM	Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-08-23 04:05PM	Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update (PR Newswire)
Feb-07-23 04:05PM	Viking Therapeutics to Present at SVB Securities Global Biopharma Conference (PR Newswire)
Feb-01-23 04:05PM	Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2022 on February 8, 2023 (PR Newswire)
Jan-12-23 06:06AM	Individual investors account for 50% of Viking Therapeutics, Inc.'s (NASDAQ:VKTX) ownership, while institutions account for 32% (Simply Wall St.)
Jan-09-23 07:05AM	Viking Therapeutics Announces Completion of Enrollment in Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) (PR Newswire)
Dec-28-22 09:29PM	12 Best 52-Week High Stocks To Buy Now (Insider Monkey) +10.85%
Dec-19-22 08:42AM	Viking Therapeutics' stock rallies after Madrigal shares positive data about its liver drug (MarketWatch) +73.88%
Dec-09-22 12:00PM	Viking Therapeutics, Inc. (VKTX) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Nov-22-22 08:30AM	My 3 Top Biotech Stock Picks for 2023 (Motley Fool)
Nov-16-22 06:01AM	A Viking Therapeutics, Inc. (NASDAQ:VKTX) insider increased their holdings by 68% last year (Simply Wall St.) -6.94%
Nov-08-22 04:05PM	Viking Therapeutics to Present at Stifel 2022 Healthcare Conference (PR Newswire)
Oct-26-22 04:05PM	Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
Oct-19-22 04:05PM	Viking Therapeutics to Report Financial Results for Third Quarter 2022 on October 26, 2022 (PR Newswire) -12.13%
Oct-06-22 03:09PM	We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth (Simply Wall St.)
Sep-15-22 11:38AM	Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon (Motley Fool)
Sep-06-22 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Aug-05-22 06:51AM	What Is The Ownership Structure Like For Viking Therapeutics, Inc. (NASDAQ:VKTX)? (Simply Wall St.) +7.86%

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rowland Charles A Jr	Director	May 16	Option Exercise	1.08	40,000	43,200	70,000	May 18 06:31 PM
MACARTNEY LAWSON	Director	May 16	Option Exercise	1.19	16,000	19,040	63,965	May 18 06:30 PM
Rowland Charles A Jr	Director	May 16	Sale	25.00	40,000	1,000,000	30,000	May 18 06:31 PM
MACARTNEY LAWSON	Director	May 16	Sale	24.00	16,000	384,000	47,965	May 18 06:30 PM
Lian Brian	President & CEO	May 01	Sale	22.45	45,000	1,010,250	2,197,963	May 01 07:03 PM
MACARTNEY LAWSON	Director	Apr 24	Option Exercise	3.33	16,000	53,280	63,965	Apr 24 07:31 PM
MACARTNEY LAWSON	Director	Apr 24	Sale	22.00	16,000	352,061	47,965	Apr 24 07:31 PM
Lian Brian	President & CEO	Apr 19	Sale	21.45	35,000	750,750	2,242,963	Apr 21 07:29 PM
Lian Brian	President & CEO	Apr 17	Option Exercise	2.15	125,000	268,750	2,432,963	Apr 18 07:09 PM
MACARTNEY LAWSON	Director	Apr 17	Option Exercise	8.00	20,786	166,288	68,751	Apr 18 07:10 PM
Mancini Marianna	Chief Operating Officer	Apr 17	Option Exercise	13.07	12,500	163,375	300,263	Apr 18 07:08 PM
ZANTE GREG	Chief Financial Officer	Apr 17	Option Exercise	13.07	7,500	98,025	156,779	Apr 18 07:07 PM
Lian Brian	President & CEO	Apr 17	Sale	20.45	155,000	3,169,766	2,277,963	Apr 18 07:09 PM
MACARTNEY LAWSON	Director	Apr 17	Sale	20.00	20,786	415,720	47,965	Apr 18 07:10 PM
Mancini Marianna	Chief Operating Officer	Apr 17	Sale	20.00	12,500	250,000	287,763	Apr 18 07:08 PM
ZANTE GREG	Chief Financial Officer	Apr 17	Sale	20.00	7,500	150,000	149,279	Apr 18 07:07 PM
Lian Brian	President & CEO	Apr 13	Option Exercise	1.88	54,336	102,152	2,387,299	Apr 13 05:14 PM
Lian Brian	President & CEO	Apr 13	Sale	18.45	79,336	1,463,749	2,307,963	Apr 13 05:14 PM
ZANTE GREG	Chief Financial Officer	Apr 12	Option Exercise	5.99	41,544	249,026	190,823	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 12	Sale	18.00	41,544	747,792	149,279	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 11	Option Exercise	5.25	56,295	295,778	205,574	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 11	Sale	18.00	56,295	1,013,518	149,279	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 03	Option Exercise	7.77	30,911	240,178	178,689	Apr 03 07:24 PM
ZANTE GREG	Chief Financial Officer	Apr 03	Sale	18.00	30,911	556,398	147,778	Apr 03 07:24 PM
Lian Brian	President & CEO	Apr 03	Sale	17.85	22,000	392,700	2,232,963	Apr 03 07:26 PM
Lian Brian	President & CEO	Mar 31	Option Exercise	9.49	67,970	645,035	2,322,933	Apr 03 07:26 PM
Lian Brian	President & CEO	Mar 31	Sale	17.45	67,970	1,186,076	2,254,963	Apr 03 07:26 PM
ZANTE GREG	Chief Financial Officer	Mar 30	Option Exercise	7.29	93,750	683,482	278,807	Apr 03 07:24 PM
Lian Brian	President & CEO	Mar 30	Option Exercise	2.42	135,382	327,838	2,408,345	Apr 03 07:26 PM
Mancini Marianna	Chief Operating Officer	Mar 30	Option Exercise	8.12	36,100	293,122	297,995	Apr 03 07:22 PM
Lian Brian	President & CEO	Mar 30	Sale	17.16	153,382	2,632,516	2,254,963	Apr 03 07:26 PM
ZANTE GREG	Chief Financial Officer	Mar 30	Sale	17.00	131,029	2,227,821	147,778	Apr 03 07:24 PM
Mancini Marianna	Chief Operating Officer	Mar 29	Option Exercise	9.13	15,000	136,950	303,137	Mar 30 09:04 PM
Mancini Marianna	Chief Operating Officer	Mar 29	Sale	16.00	41,242	659,872	261,895	Mar 30 09:04 PM
Mancini Marianna	Chief Operating Officer	Mar 28	Option Exercise	2.37	167,427	397,193	484,700	Mar 30 09:04 PM
Mancini Marianna	Chief Operating Officer	Mar 28	Sale	15.00	196,563	2,948,445	288,137	Mar 30 09:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX | Viking Therapeutics Inc

Upgrade your FINVIZ experience